189 related articles for article (PubMed ID: 19915746)
1. A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line.
Aranda E; Owen GI
Biol Res; 2009; 42(3):377-89. PubMed ID: 19915746
[TBL] [Abstract][Full Text] [Related]
2. Matrigel cytometry: a novel method for quantifying angiogenesis in vivo.
Adini A; Fainaru O; Udagawa T; Connor KM; Folkman J; D'Amato RJ
J Immunol Methods; 2009 Mar; 342(1-2):78-81. PubMed ID: 19109967
[TBL] [Abstract][Full Text] [Related]
3. Identification of HIV-1 Tat peptides for future therapeutic angiogenesis.
Ismail M; Henklein P; Huang X; Braumann C; Rückert RI; Dubiel W
Eur J Haematol; 2006 Aug; 77(2):157-65. PubMed ID: 16800839
[TBL] [Abstract][Full Text] [Related]
4. In vitro model of angiogenesis using a human endothelium-derived permanent cell line: contributions of induced gene expression, G-proteins, and integrins.
Bauer J; Margolis M; Schreiner C; Edgell CJ; Azizkhan J; Lazarowski E; Juliano RL
J Cell Physiol; 1992 Dec; 153(3):437-49. PubMed ID: 1280276
[TBL] [Abstract][Full Text] [Related]
5. [A new in vitro model to quantify angiogenesis].
Bahramsoltani M; Plendl J
ALTEX; 2004; 21(4):227-44. PubMed ID: 15586254
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight peptides derived from extracellular matrix as chemoattractants for primary endothelial cells.
Li F; Li W; Johnson S; Ingram D; Yoder M; Badylak S
Endothelium; 2004; 11(3-4):199-206. PubMed ID: 15370297
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic efficacy of grape seed extract in endothelial cells.
Agarwal C; Singh RP; Dhanalakshmi S; Agarwal R
Oncol Rep; 2004 Mar; 11(3):681-5. PubMed ID: 14767522
[TBL] [Abstract][Full Text] [Related]
9. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
10. The HUVEC/Matrigel assay: an in vivo assay of human angiogenesis suitable for drug validation.
Skovseth DK; Küchler AM; Haraldsen G
Methods Mol Biol; 2007; 360():253-68. PubMed ID: 17172733
[TBL] [Abstract][Full Text] [Related]
11. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor.
Morais C; Gobe G; Johnson DW; Healy H
Angiogenesis; 2009; 12(4):365-79. PubMed ID: 19882112
[TBL] [Abstract][Full Text] [Related]
13. Development of a one-step embryonic stem cell-based assay for the screening of sprouting angiogenesis.
Hermant B; Desroches-Castan A; Dubessay ML; Prandini MH; Huber P; Vittet D
BMC Biotechnol; 2007 Apr; 7():20. PubMed ID: 17437635
[TBL] [Abstract][Full Text] [Related]
14. Novel function of ascorbic acid as an angiostatic factor.
Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S
Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494
[TBL] [Abstract][Full Text] [Related]
15. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
16. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
[TBL] [Abstract][Full Text] [Related]
17. In vitro angiogenic effects of pancreatic bile salt-dependent lipase.
Rebaï O; Le Petit-Thevenin J; Bruneau N; Lombardo D; Vérine A
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):359-64. PubMed ID: 15569825
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of ETS and MMP factors in VEGF-activated endothelial cells: role of MMP-10 in VEGF-induced angiogenesis.
Heo SH; Choi YJ; Ryoo HM; Cho JY
J Cell Physiol; 2010 Sep; 224(3):734-42. PubMed ID: 20432469
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis.
Hung SC; Pochampally RR; Chen SC; Hsu SC; Prockop DJ
Stem Cells; 2007 Sep; 25(9):2363-70. PubMed ID: 17540857
[TBL] [Abstract][Full Text] [Related]
20. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.
Passaniti A; Taylor RM; Pili R; Guo Y; Long PV; Haney JA; Pauly RR; Grant DS; Martin GR
Lab Invest; 1992 Oct; 67(4):519-28. PubMed ID: 1279270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
